Triatomic Management’s Guardant Health GH Stock Holding History

Triatomic Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,000	Closed	-$216K	–	32
2023 Q4	$216K	Sell	8,000 -2,000	-20%	-$52.5K	0.28%	31
2023 Q3	$296K	Sell	10,000 -10,000	-50%	-$352K	0.2%	45
2023 Q2	$716K	Sell	20,000 -15,072	-43%	-$433K	0.73%	26
2023 Q1	$822K	Buy	+35,072	New	+$1M	0.55%	29
2022 Q2	–	Sell	-29,097	Closed	-$1.93M	–	47
2022 Q1	$1.93M	Buy	29,097 +2,500	+9%	+$171K	1.57%	16
2021 Q4	$2.66M	Buy	+26,597	New	+$2.75M	1.63%	17

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Triatomic Management's GH Position: Q1 2024 in Review

Triatomic Management sold out of Guardant Health (GH) in Q1 2024, closing a stake of 8,000 shares — an estimated $216K sold.

Triatomic Management first reported a position in GH in Q4 2021 and held it in 6 quarters. The position peaked at $2.66M in Q4 2021. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

Triatomic Management reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
Triatomic Management sold 8,000 Guardant Health shares in Q1 2024, an estimated $216K.
Triatomic Management first reported a position in Guardant Health in Q4 2021 and held it in 6 quarters.
Triatomic Management's Guardant Health position peaked at $2.66M in Q4 2021.
258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Triatomic Management's 13F filing for Q1 2024, filed 13 May 2024.